Eveline Van Keymeulen is a Partner at Latham & Watkins' Brussels and Paris offices and Global Vice Chair of the Life Sciences Practice and Industry Groups. Eveline advises multinational companies and start-ups as well as trade associations in the pharmaceutical, medical technology, and biotech sectors on a broad variety of complex European, domestic and cross-border regulatory matters, including clinical trials, product approvals, regulatory incentives, market access, promotion and advertising, post-market obligations, and general compliance matters. She regulatory counsels clients on the interface between pharmaceutical, medical device, big data and technology regulations and provides strategic advice on regulatory pathways to market novel products in the EU. Ms. Van Keymeulen is a trusted legal and policy advisor to the European Federation of Pharmaceutical Industries and Associations (EFPIA) and has authored numerous articles and has been a featured speaker on EU regulatory matters at prominent conferences such as the European Pharma Law Academy in Cambridge. Ms. Van Keymeulen also serves on the editorial board of the European Pharmaceutical Law Review. In addition, Ms. Van Keymeulen has been quoted in BBC Business Daily, Bloomberg, The Times, Les Echos and other leading international business journals on life sciences regulatory and policy matters.